Sign In
Buy ARVN
$7.70
-0.300 (-3.75%)
At Close: Jun 03, 2026
Arvinas Inc (NASDAQ:ARVN) CFO Sean A. Cassidy Sells 1,514 Shares
09:58am, Tuesday, 24'th Mar 2020
Arvinas Inc (NASDAQ:ARVN) CFO Sean A. Cassidy sold 1,514 shares of the business’s stock in a transaction dated Thursday, March 19th. The stock was sold at an average price of $37.61, for a total val
Arvinas Inc (NASDAQ:ARVN) Director Timothy M. Shannon Buys 2,500 Shares of Stock
08:46am, Tuesday, 24'th Mar 2020
Arvinas Inc (NASDAQ:ARVN) Director Timothy M. Shannon purchased 2,500 shares of the stock in a transaction dated Friday, March 20th. The shares were purchased at an average price of $35.13 per share,
Arvinas Inc (NASDAQ:ARVN) CEO John G. Houston Sells 5,405 Shares
08:10am, Tuesday, 24'th Mar 2020
Arvinas Inc (NASDAQ:ARVN) CEO John G. Houston sold 5,405 shares of the firm’s stock in a transaction that occurred on Thursday, March 19th. The stock was sold at an average price of $37.61, for a to
Arvinas Inc to Post FY2020 Earnings of ($2.94) Per Share, Wedbush Forecasts (NASDAQ:ARVN)
06:50am, Monday, 23'rd Mar 2020
Arvinas Inc (NASDAQ:ARVN) – Investment analysts at Wedbush raised their FY2020 earnings per share estimates for shares of Arvinas in a research note issued on Wednesday, March 18th. Wedbush analyst
Independent Director Bradley Margus Just Sold A Bunch Of Shares In Arvinas, Inc. (NASDAQ:ARVN)
01:46pm, Sunday, 22'nd Mar 2020
We wouldn't blame Arvinas, Inc. (NASDAQ:ARVN) shareholders if they were a little worried about the fact that Bradley...
Bradley Albert Margus Sells 40,000 Shares of Arvinas Inc (NASDAQ:ARVN) Stock
09:10am, Sunday, 22'nd Mar 2020
Arvinas Inc (NASDAQ:ARVN) Director Bradley Albert Margus sold 40,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 18th. The stock was sold at an average price of
Arvinas (NASDAQ:ARVN) Upgraded to "Buy" by Zacks Investment Research
09:32am, Saturday, 21'st Mar 2020
Zacks Investment Research upgraded shares of Arvinas (NASDAQ:ARVN) from a hold rating to a buy rating in a report issued on Tuesday, Zacks.com reports. The brokerage currently has $37.00 target price
Is Arvinas (ARVN) Outperforming Other Medical Stocks This Year?
03:30pm, Friday, 20'th Mar 2020
Is (ARVN) Outperforming Other Medical Stocks This Year?
Is Arvinas (ARVN) Outperforming Other Medical Stocks This Year?
03:30pm, Friday, 20'th Mar 2020
Is (ARVN) Outperforming Other Medical Stocks This Year?
Analyst Estimates: Here’s What Brokers Think Of Arvinas, Inc. (NASDAQ:ARVN) After Its Yearly Report
10:05am, Friday, 20'th Mar 2020
As you might know, Arvinas, Inc. (NASDAQ:ARVN) recently reported its full-year numbers. It looks like a positive...
Why You Shouldn't Bet Against Arvinas (ARVN) Stock
12:56pm, Thursday, 19'th Mar 2020
Arvinas (ARVN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Why You Shouldn't Bet Against Arvinas (ARVN) Stock
12:56pm, Thursday, 19'th Mar 2020
Arvinas (ARVN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Confessions of an immune-compromised health journalist - BizNews.com
11:30am, Thursday, 19'th Mar 2020
Oncologist said bluntly with my borderline blood count, if kids have friends around on play dates and infected with any virus let alone Covid I will die.
ArrowMark Colorado Holdings LLC Raises Stock Holdings in Arvinas Inc (NASDAQ:ARVN)
08:42am, Thursday, 19'th Mar 2020
ArrowMark Colorado Holdings LLC increased its position in Arvinas Inc (NASDAQ:ARVN) by 657.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission
Is Arvinas (NASDAQ:ARVN) A Risky Investment?
10:52am, Wednesday, 18'th Mar 2020
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
